University of California San Francisco
Give to UCSF
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of
Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more
A study finds personalized breast cancer screening based on risk reduces advanced cancers and ensures safe, tailored mammogram frequency.
A study shows that young people who use tanning beds have more skin mutations including cells known to lead to skin cancer.
Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid
The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny “pocket” on a protein that signals the cells to grow and divide was discovered, leading to the world's first FDA-approved drugs that can now target and destroy these cancer cells.
Senescent fibroblasts are aging cells in connective tissue that no longer divide and protect against tumor development. Yet, these same cells can promote cancer growth in a laboratory setting.Until
Lee May, diagnosed with aggressive multiple myeloma at 59, defied odds with cutting-edge treatments at UCSF Health, including CAR-T therapy and NIH-funded innovations. Now 74 and in remission, May credits advanced research for his survival. UCSF leads the way in transforming blood cancer care.
Neurologist Dr. Ptacek explains how "falling back" disrupts the 24-hour circadian clock, affecting mood and performance, with mitigation tips.
UCSF radiation oncologist David Raleigh, MD, PhD, studies the link between brain tumors and injectable birth control.
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to
Ahead of the 2025 Nobel Prize announcements, we take a look back at UCSF's Nobel laureates, their discoveries, and the UCSF research building on their work today.
Thanks to funding from the National Institutes of Health (NIH), UC San Francisco researchers are revolutionizing what we thought we knew about how cancer spreads, opening new paths to cures.
A study led by UCSF and UC Davis concluded that radiation from medical imaging is associated with a higher risk of blood cancers in children.
A new study from UCSF is the first to show a statistically significant increased risk of death in children with acute lymphoblastic leukemia exposed to any pesticide during or after pregnancy.
The UCSF Helen Diller Family Comprehensive Cancer Center announced today the awarding of a Specialized Programs of Research Excellence (SPORE) grant by the National Cancer Institute (NCI) for a
Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC
UCSF researchers studied personalized chemotherapy conditioning for children to maximize chemotherapy exposure for each child versus the current generalized dosage based on weight and age. Their approach reveals higher survival and lower recurrence rates.
A new grant paves the way for UCSF to train one of Mexico’s first molecular pediatric pathologists, providing access to better cancer detection and treatment for the thousands of children diagnosed with cancer in Mexico every year.
A UCSF-led study finds a new class of insecticide that can be disseminated on material the size of a sheet of paper that offers protection for up to a year against mosquitoes that spread malaria, as well as dengue, West Nile, yellow fever, and Zika.
A UCSF team discover how breast cancer tumors tunnel into neighboring fat cells to trigger fat breakdown in order to feed on fat and grow.
A UCSF team develops a new drug for malaria that could address one of the disease's biggest challenges - the spread of parasites that resist the most commonly-used medications.
UC San Francisco’s Paul Farmer African Initiative for Research (PFAIR) supports African scientists in infectious disease research via mentorship, international collaboration, and sustainable funding.
A $100 million matching grant from the Weill Family Foundation is bringing together two leading cancer centers to launch the Weill Cancer Hub West — an innovative collaboration among some of the nation’s most talented scientists that aims to transform cancer research and care in the next decade.
